BioAtla, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

BioAtla, Inc. reported Cash And Cash Equivalents At Carrying Value of $7.12 million for the year ending 2025.

  • BioAtla, Inc. showed a decrease of -85.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from BioAtla, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), BioAtla, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 34.5%.
  • Historical annual values: Fiscal year 2025: $7.12 million | Fiscal year 2024: $49.05 million | Fiscal year 2023: $111.47 million | Fiscal year 2022: $215.51 million | Fiscal year 2021: $244.98 million | Fiscal year 2020: $238.61 million | Fiscal year 2019: $3.70 million | Fiscal year 2018: $10.86 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: